FR167653, a p38 mitogen-activated protein kinase inhibitor, aggravates experimental colitis in mice

doi:10.3748/wjg.14.5851

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 38

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4618)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-5) series.

Item

Count

PDF

345

HTML

3746

Figures (1-5)

527

Sum=4618

Oct 14, 2008 (publication date) through May 6, 2024

Times Cited of This Article

Times Cited (11)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Research

World J Gastroenterol. Oct 14, 2008; 14(38): 5851-5856
Published online Oct 14, 2008. doi: 10.3748/wjg.14.5851

Full Size Figure Download Figure

Figure 4 Histological analyses for FR167653 effects on DSS colitis. Colons were excised after 14 d of DSS treatment and stained with HE, anti-CD4 antibody, and anti-F4/80 antibody.

Citation: Nishimura T, Andoh A, Nishida A, Shioya M, Koizumi Y, Tsujikawa T, Fujiyama Y. FR167653, a p38 mitogen-activated protein kinase inhibitor, aggravates experimental colitis in mice. World J Gastroenterol 2008; 14(38): 5851-5856
URL: https://www.wjgnet.com/1007-9327/full/v14/i38/5851.htm
DOI: https://dx.doi.org/10.3748/wjg.14.5851